Sermorelin (5mg)
$52.99
Sermorelin is a synthetic peptide analogue representing the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH 1-29-NH₂). In research settings, Sermorelin is studied for its binding interactions with pituitary GHRH receptors, somatotroph cell biology, and GH secretion dynamics relative to full-length GHRH.
BioRhex supplies Sermorelin as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- COA-verified
- In stock
- ≥99% purity.
- USA manufactured.
What Is Sermorelin?
Sermorelin is a synthetic peptide analogue representing the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH 1-29-NH₂). In research settings, Sermorelin is studied for its binding interactions with pituitary GHRH receptors, somatotroph cell biology, and GH secretion dynamics relative to full-length GHRH.
BioRhex supplies Sermorelin as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Compound Overview
Sermorelin is a truncated GHRH analogue studied for its receptor activity and GH axis interactions. In vitro and preclinical research models examine how Sermorelin may influence:
• GHRH receptor binding and somatotroph activation dynamics
• Pulsatile GH secretion pattern modeling
• Hypothalamic-pituitary axis feedback interactions
• IGF-1 downstream signaling in experimental models
• GH axis pharmacology relative to full-length 44-residue GHRH
All findings referenced are from controlled research environments and do not represent clinical outcomes or therapeutic claims.
History of Sermorelin
Sermorelin was developed as the shortest biologically active GHRH fragment retaining receptor binding and GH stimulation activity. The 29-amino-acid sequence contains the core receptor-binding domain of GHRH while offering a structurally simpler, more readily synthesized research tool.
Its use in research allowed scientists to study GHRH receptor biology and GH axis pharmacology without requiring full-length GHRH synthesis, and to establish structure-activity relationships within the GHRH sequence.
Sermorelin remains a commonly referenced GHRH analogue in GH axis research within controlled laboratory settings.
Molecular Structure
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
Research Findings
Published and preclinical research on Sermorelin covers several areas of scientific investigation, including:
GHRH receptor pharmacology: Studies examine Sermorelin’s binding affinity and activation efficacy at pituitary GHRH receptors relative to full-length GHRH.
GH secretion modeling: Research investigates GH pulse patterns induced by Sermorelin receptor activation in preclinical experimental systems.
Axis feedback research: Laboratory models explore somatostatin and feedback regulation of GH secretion following Sermorelin stimulation.
IGF-1 pathway interactions: Studies evaluate downstream IGF-1 modulation in response to Sermorelin-induced GH axis activity.
All findings referenced are from controlled, non-clinical research models and do not imply therapeutic or clinical application.
References
FAQ
What type of research is Sermorelin used for?
What type of research is Sermorelin used for?
Sermorelin is used in laboratory research settings. All supplied compounds are intended strictly for in vitro and preclinical research purposes. Use is limited to controlled scientific environments.
Where is BioRhex’s Sermorelin manufactured?
Where is BioRhex’s Sermorelin manufactured?
All BioRhex compounds, including Sermorelin, are manufactured in a GMP-compliant facility located in the United States.
What testing does BioRhex conduct on Sermorelin?
What testing does BioRhex conduct on Sermorelin?
Every batch of Sermorelin undergoes third-party HPLC purity testing, mass spectrometry identity verification, and sterility testing. A Certificate of Analysis is included with every order, documenting batch-specific purity data at a ≥99% threshold.
Is Sermorelin approved for human use?
Is Sermorelin approved for human use?
No. Sermorelin is not FDA-approved and is not intended for human or animal administration. It is supplied exclusively for laboratory research purposes.
Who should handle this compound?
Who should handle this compound?
Only qualified personnel in controlled laboratory settings following appropriate safety and handling protocols.
Research Use Only
All BioRhex compounds are supplied strictly for laboratory research purposes. Not for human or animal consumption, medical use, or therapeutic application. Sermorelin is not FDA-approved for any medical purpose. Nothing on this page should be interpreted as health guidance or applied outside controlled research settings.
RELATED PRODUCTS
AOD9604 (5mg)
BPC-157
BPC-157 + TB-500
CJC (no DAC) + Ipamorelin (10mg)
